Learning the Lung Cancer Landscape in Hanover

Sep 6, 2018

We traveled to Hanover, Maryland for a State of the Science SummitTM on Advanced Non–Small Cell Lung Cancer. The meeting covered the use of immunotherapy in metastatic and early-stage disease, management of immune-related toxicities, predictive biomarkers, and emerging therapies in small cell lung cancer.

We traveled to Hanover, Maryland for a State of the Science SummitTM on Advanced Non—Small Cell Lung Cancer. The meeting covered the use of immunotherapy in metastatic and early-stage disease, management of immune-related toxicities, predictive biomarkers, and emerging therapies in small cell lung cancer.

Related Content